Quarterly report · Q2
9993.TEDINET S100PCDS
Period2022-03-01 → 2022-08-31
Filed2022-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥110.7bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.2bn | 2021-03-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥683m | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥579m | 2021-03-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥726m | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥602m | 2021-03-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥663m | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥576m | 2021-03-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥368m | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥367m | 2021-03-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥367m | 2021-03-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥50.5bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥49.4bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥51.5bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥21.3bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥20.6bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥29.2bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥28.8bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥29.0bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.2bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2021-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.1bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥483m | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥699m | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6m | 2021-03-01 → 2021-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.78 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.08 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.76 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.71 | 2021-03-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.05 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.75 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.74 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.68 | 2021-03-01 → 2021-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 57.7% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.3% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-03-01 → 2022-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-03-01 → 2022-08-31 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-08-31 | −¥2m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥49m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥44.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥43.8bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥579m |
| —segment total | revenue | 2022-03-01 → 2022-08-31 | ¥50.6bn |
| —segment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| —segment total | segment profit | 2022-03-01 → 2022-08-31 | ¥628m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-08-31 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-08-31 | ¥685m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-03-01 → 2021-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-03-01 → 2021-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-03-01 → 2021-08-31 | ¥66m |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2021-08-31 | −¥2.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2021-08-31 | −¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2021-08-31 | ¥17m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥6.6bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥6.6bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2021-03-01 → 2021-08-31 | ¥14m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2021-03-01 → 2021-08-31 | ¥49.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2021-03-01 → 2021-08-31 | ¥48.6bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥481m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2021-03-01 → 2021-08-31 | ¥480m |
| —segment total | revenue | 2021-03-01 → 2021-08-31 | ¥55.7bn |
| —segment total | revenue external | 2021-03-01 → 2021-08-31 | ¥55.2bn |
| —segment total | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥481m |
| —segment total | segment profit | 2021-03-01 → 2021-08-31 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-03-01 → 2021-08-31 | ¥57.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-03-01 → 2021-08-31 | ¥55.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-03-01 → 2021-08-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-03-01 → 2021-08-31 | ¥561m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 1552000000 | JPY |
| Other ncl | CurrentQuarterInstant | 1484000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 4233000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 4966000000 | JPY |
| Liabilities | Prior1YearInstant | 20561000000 | JPY |
| Liabilities | CurrentQuarterInstant | 21335000000 | JPY |
| Capital stock | Prior1YearInstant | 2388000000 | JPY |
| Capital stock | CurrentQuarterInstant | 2388000000 | JPY |
| Capital surplus | Prior1YearInstant | 2209000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 2211000000 | JPY |
| Retained earnings | Prior1YearInstant | 24247000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 24574000000 | JPY |
| Treasury stock | Prior1YearInstant | -67000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -60000000 | JPY |
| Shareholders equity | Prior1YearInstant | 28778000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 29113000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 10000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 21000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 11000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 9000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 21000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 31000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 12000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 12000000 | JPY |
| Net assets | Prior1YearInstant | 28812000000 | JPY |
| Net assets | CurrentQuarterInstant | 29157000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 49373000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 50493000000 | JPY |
| Net sales | Prior1YTDDuration | 55227000000 | JPY |
| Net sales | CurrentYTDDuration | 50309000000 | JPY |
| Cost of sales | Prior1YTDDuration | 39579000000 | JPY |
| Cost of sales | CurrentYTDDuration | 36612000000 | JPY |
| Gross profit | Prior1YTDDuration | 15647000000 | JPY |
| Gross profit | CurrentYTDDuration | 13696000000 | JPY |
| Salaries sga | Prior1YTDDuration | 5420000000 | JPY |
| Salaries sga | CurrentYTDDuration | 5418000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 291000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 296000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 53000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 50000000 | JPY |
| Provision for point card certificates sga | Prior1YTDDuration | 648000000 | JPY |
| Provision for point card certificates sga | CurrentYTDDuration | － | JPY |
| Depreciation sga | Prior1YTDDuration | 1277000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 1309000000 | JPY |
| Other sga | Prior1YTDDuration | 7375000000 | JPY |
| Other sga | CurrentYTDDuration | 5937000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 15067000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 13012000000 | JPY |
| Operating income | Prior1YTDDuration | 579000000 | JPY |
| Operating income | CurrentYTDDuration | 683000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |